Addition of algenpantucel-L immunotherapy to standard of care (SOC) adjuvant therapy for pancreatic cancer.
Jeffrey M Hardacre
No relevant relationships to disclose
Mary Frances Mulcahy
No relevant relationships to disclose
William Small
No relevant relationships to disclose
Mark S. Talamonti
No relevant relationships to disclose
Jennifer Carrie Obel
No relevant relationships to disclose
Caio Max S. Rocha Lima
No relevant relationships to disclose
Howard Safran
No relevant relationships to disclose
Heinz-Josef Lenz
No relevant relationships to disclose
E. Gabriela Chiorean
No relevant relationships to disclose
Nicholas N. Vahanian
Employment or Leadership Position - Newlink Genetics
Stock Ownership - Newlink Genetics
Charles J. Link
Employment or Leadership Position - Newlink Genetics
Stock Ownership - Newlink Genetics